| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |